Organising pneumonia (otherwise referred to as bronchiolitis obliterans organising pneumonia) is characterised histologically by plugs of granulation tissue, which are present predominantly within small airways, alveolar ducts and peri-bronchiolar alveoli. This pattern is not specific for any disorder or cause, but is one type of inflammatory response to pulmonary injury, which may be seen in a wide variety of clinical conditions. Typically, organising pneumonia responds very well to corticosteroid treatment; however, a small percentage of patients appear to develop progressive fibrosis.
Interstitial lung diseases (ILD) are a heterogeneous group characterised by variable amounts of inflammation and fibrosis. However, the development of pulmonary fibrosis is associated with a poorer prognosis. Although distinct histological features differentiate between the ILDs, it is unknown if there are shared pathogenic mechanisms involved in the development of fibrosis. Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of familial and sporadic idiopathic pulmonary fibrosis (IPF). In response to ER stress, cells trigger the unfolded protein response (UPR) and upregulate chaperones, such as BiP, and the phosphatase GADD34, which can regulate epithelial to mesenchyme transition, cell proliferation, apoptosis and cell survival.AimsWe hypothesise that ER stress may be involved in the pathogenesis of fibrosis in all interstitial lung diseases.MethodsParaffin embedded sections, obtained from video assisted thoracoscopic diagnostic lung biopsies, from 8 patients with familial pulmonary fibrosis, 11 sporadic idiopathic pulmonary fibrosis (IPF), 12 non-specific interstitial pneumonia (NSIP) and 10 hypersensitivity pneumonitis (HP) were evaluated for BiP and GADD34 by immunohistochemistry. Using light microscopy, 6 high power fields were scored for fibrosis, inflammation, BiP and GADD34 using semi-quantitative analysis by 2 blinded, independent investigators. Data were analysed by linear regression using Prism software.ResultsOf the 41 biopsy samples analysed, 20 (49%) were non-smokers and 18 (44%) were male. BiP and GADD34 were localised to reactive type II pneumocytes and columnar epithelium within areas of fibrosis. GADD34 was also evident in the endothelium. No staining was detected within fibroblasts or fibroblastic foci. Epithelial GADD34 correlated with extent of fibrosis in familial pulmonary fibrosis (r2=0.72 p<0.001), IPF (r2=0.51 p<0.0001) and NSIP (r2=0.46 p<0.0001). In contrast, BiP was associated with fibrosis in IPF (r2=0.49 p<0.0001) and HP (r2=0.59 p<0.0001). There was no association with inflammation.ConclusionThese data show that ER stress and the UPR are associated with fibrotic ILDs. Hence targeting ER stress may be a novel therapeutic option for pulmonary fibrosis. Work is on going to identify a peripheral biomarker signature for ER stress.
Results Compared with normoxia, hypoxia promoted PMN survival (mean% ± SEM apoptotic cells at 20 h; 30.9 ± 1.9 vs. 59.0 ± 1.8 respectively, p < 0.0001). Both pan-PI3-K inhibitors reversed the pro-survival effect of hypoxia in a concentrationdependent manner, LY294002 (10 µM; 60.3 ± 4.0, p < 0.0001) and ZSTK474 (10 µM; 58.3 ± 2.6, p < 0.0001) without affecting the basal rate of apoptosis. This effect was not seen with the dual PI3-Kdg inhibitor (3 µM; 43.8 ± 7.6) or individual PI3-Kd (1 µM; 43.0 ± 5.8) and g inhibitors (3 µM; 34.9 ± 4.5 and 10 µM; 32.6 ± 3.6). Conclusions Our results indicate that hypoxia-induced PMN survival is PI3-K dependent. Targeting this pathway may accelerate PMN apoptosis, resulting in resolution of inflammation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.